|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-3-6
|
|
pubmed:abstractText |
Uveitis often runs a chronic course requiring long-term therapy. Topical treatment results in poor intravitreal penetration, and systemic therapy is associated with significant side effects. The authors investigated whether an intravitreal sustained-release dexamethasone device was effective in the treatment of severe panuveitis in a rabbit model.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0146-0404
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
442-53
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7843913-Animals,
pubmed-meshheading:7843913-Antigens, Bacterial,
pubmed-meshheading:7843913-Ciliary Body,
pubmed-meshheading:7843913-Cornea,
pubmed-meshheading:7843913-Delayed-Action Preparations,
pubmed-meshheading:7843913-Dexamethasone,
pubmed-meshheading:7843913-Disease Models, Animal,
pubmed-meshheading:7843913-Drug Delivery Systems,
pubmed-meshheading:7843913-Electroretinography,
pubmed-meshheading:7843913-Mycobacterium tuberculosis,
pubmed-meshheading:7843913-Panuveitis,
pubmed-meshheading:7843913-Postoperative Complications,
pubmed-meshheading:7843913-Rabbits,
pubmed-meshheading:7843913-Retina,
pubmed-meshheading:7843913-Vitreous Body
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
|
|
pubmed:affiliation |
Department of Ophthalmology, Duke University Medical Center, North Carolina 27710.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
